Abstract:The action of protein kinases and protein phosphatases is essential for multiple physiological responses. Each protein kinase displays its own unique substrate specificity and a regulatory mechanism that may be modulated by association with other proteins. Protein kinases are classified as dual-specificity kinases and dual-specificity phosphatases. Dual-specificity phosphatases are important signal transduction enzymes that regulate various cellular processes in coordination with protein kinases and play an important role in obesity. Impairment of insulin signaling in obesity is largely mediated by the activation of the inhibitor of kappa B-kinase beta and the c-Jun N-terminal kinase (JNK). Oxidative stress and endoplasmic reticulum (ER) stress activate the JNK pathway which suppresses insulin biosynthesis. Adenosine monophosphate (AMP)-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) are important for proper regulation of glucose metabolism in mammals at both the hormonal and cellular levels. Additionally, obesity-activated calcium/calmodulin dependent-protein kinase II/p38 suppresses insulin-induced protein kinase B phosphorylation by activating the ER stress effector, activating transcription factor-4. To alleviate lipotoxicity and insulin resistance, promising targets are pharmacologically inhibited. Nifedipine, calcium channel blocker, stimulates lipogenesis and adipogenesis by downregulating AMPK and upregulating mTOR, which thereby enhances lipid storage. Contrary to the nifedipine, metformin activates AMPK, increases fatty acid oxidation, suppresses fatty acid synthesis and deposition, and thus alleviates lipotoxicity. Obese adults with vascular endothelial dysfunction have greater endothelial cells activation of unfolded protein response stress sensors, RNA-dependent protein kinase-like ER eukaryotic initiation factor-2 alpha kinase (PERK), and activating transcription factor-6. The transcriptional regulation of adipogenesis in obesity is influenced by AGC (protein kinase A (PKA), PKG, PKC) family signaling kinases. Obesity may induce systemic oxidative stress and increase reactive oxygen species in adipocytes. An increase in intracellular oxidative stress can promote PKC-β activation. Activated PKC-β induces growth factor adapter Shc phosphorylation. Shc-generated peroxides reduce mitochondrial oxygen consumption and enhance triglyceride accumulation and lipotoxicity. Liraglutide attenuates mitochondrial dysfunction and reactive oxygen species generation. Co-treatment of antiobesity and antidiabetic herbal compound, berberine with antipsychotic drug olanzapine decreases the accumulation of triglyceride. While low-dose rapamycin, metformin, amlexanox, thiazolidinediones, and saroglitazar protect against insulin resistance, glucagon-like peptide-1 analog liraglutide inhibits palmitate-induced inflammation by suppressing mTOR complex 1 (mTORC1) activity and protects against lipotoxicity.

A central role for JNK in obesity and insulin resistance

MNK1 and MNK2 Mediate Adverse Effects of High-Fat Feeding in Distinct Ways

c-Jun N-terminal Kinase 1 ablation protects against metabolic-induced hippocampal cognitive impairments

11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes

Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes

Skeletal Muscle–Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance

Nuclear Factor Κb–inducing Kinase Activation As a Mechanism of Pancreatic Β Cell Failure in Obesity

Role of transcription factor NFAT in glucose and insulin homeostasis

NK cell-activating receptor NKp46 does not participate in the development of obesity-induced inflammation and insulin resistance

MAPK/JNK signaling: A potential autophagy regulation pathway.

MyD88-dependent Interplay Between Myeloid and Endothelial Cells in the Initiation and Progression of Obesity-Associated Inflammatory Diseases.

Activation of NF-κB-Inducing Kinase in Islet β Cells Causes β Cell Failure and Diabetes

Regulation of Adipose Tissue Inflammation and Insulin Resistance by MAPK Phosphatase 5.

Protein Kinases in Obesity, and the Kinase-Targeted Therapy

Molecular Mechanism of Insulin Resistance and Obesity

JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma

c-Jun N-terminal kinase signaling in cellular senescence

JAK-STAT pathway activation compromises nephrocyte function in a high-fat diet model of chronic kidney disease

Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

Amp-Activated Protein Kinase Alpha 1 Protects Against Diet-Induced Insulin Resistance And Obesity